tw
 
tw

Mylan全球

關閉

請從下面的列表中選擇欲拜訪的網站。

  1. 非洲

    1. 南非
      1. English
  2. 美洲

    1. 加拿大
      1. English
      2. Français
    2. 巴西
      1. Português brasileiro
    3. 美國
      1. English
  3. 亞洲

      1. ไทย
      1. English
      2. Arabic
    1. 印度
      1. English
    2. 台灣
      1. 台灣
    3. 日本
      1. 日本語
  4. 歐洲

    1. 丹麥
      1. Dansk
    2. 保加利亞
      1. България
    3. 克羅地亞
      1. Croatian
    4. 匈牙利
      1. Magyar
    5. 塞爾維亞
      1. Serbian Latin
    6. 奥地利
      1. Deutsch
    7. 希臘
      1. Ελληνικά
    8. 德國
      1. Deutsch
    9. 愛爾蘭
      1. English
    10. 挪威
      1. Norsk
    11. 捷克共和國
      1. Čeština
    12. 斯洛伐克
      1. Slovenský
    13. 斯洛維尼亞
      1. Slovenian
    14. 比利時
      1. Français
      2. Nederlands
    15. 法國
      1. Français
    16. 波蘭
      1. Polski
    17. 瑞典
      1. Svensk
    18. 瑞士
      1. Deutsch
      2. English
    19. 羅馬尼亞
      1. Romanian
    20. 義大利
      1. Italiano
    21. 芬蘭
      1. Suomi
    22. 英國
      1. English
    23. 荷蘭
      1. Nederlands
    24. 葡萄牙
      1. Português
    25. 西班牙
      1. Español
  5. 南太平洋

    1. 澳洲
      1. English
    2. 紐西蘭
      1. English

Mylan也很自豪在這些地方服務。

  1. 摩洛哥
  1. 新加坡
Feb 28, 2014

Mylan to Present at the Barclays Global Healthcare Conference

PITTSBURGH, Feb. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that the Company will present at the Barclays Global Healthcare Conference on Tuesday, March 11, 2014, in  Miami. The presentation is scheduled to begin at 2:00 p.m. ET. 

Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's Web site at http://mylan.com/investors. An archived version will also be available following the live presentation and can be accessed at the same location for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,300 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com

 

SOURCE Mylan Inc.

For further information: Nina Devlin (Media) 724.514.1968 or Kris King (Investors) 724.514.1813